These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36535971)

  • 41. Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: An open-label randomized controlled study.
    Dani C; Napolitano M; Barone C; Manna A; Nigro G; Scarpelli G; Bonanno E; Gatto S; Cavigioli F; Forcellini C; Petoello E; Beghini R; Ciarcià M; Fusco M; Mosca F; Lavizzari A; Gitto E; Barbuscia L; Betta P; Mattia C; Corvaglia L; Vedovato S; Vento G; Maffei G; Falsaperla R; Lago P; Boni L; Lista G;
    Pediatr Pulmonol; 2024 Apr; 59(4):1006-1014. PubMed ID: 38441525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
    Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
    BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Beractant Administration by Thin Catheter vs Intubation-Surfactant-Extubation (INSURE) in Preterm Infants Less than 34 Weeks Gestational Age with Respiratory Distress Syndrome - A Single Centre Experience.
    Patra S; Manerkar S; Kaur S; Kalathingal T; Kalamdani P; Bhisikar S; Mondkar J
    J Neonatal Perinatal Med; 2023; 16(2):239-245. PubMed ID: 37270819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early or later prophylactic INSURE in preterm infants of less than 30 weeks' gestation.
    Okulu E; Arsan S; Mungan Akın İ; Alan S; Kılıç A; Atasay B
    Turk J Pediatr; 2015; 57(1):1-8. PubMed ID: 26613214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Comparison of LISA and INSURE techniques in term of neonatal morbidities and mortality among premature infants.
    Silahli M; Tekin M
    Acta Biomed; 2020 Nov; 91(4):e2020189. PubMed ID: 33525282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-INSURE Administration of Heated Humidified High-Flow Therapy Versus Nasal Continuous Positive Airway Pressure in Preterm Infants More Than 28 Weeks Gestation with Respiratory Distress Syndrome: A Randomized Non-Inferiority Trial.
    Singh S; Ananthan A; Nanavati R
    J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35877150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-Term Outcome after Repeated Less Invasive Surfactant Administration: A Retrospective Cohort Study.
    Kleijkers LMP; Van Der Spil J; Janssen LCE; Dieleman JP; Andriessen P; van Kaam AH; Onland W; Niemarkt HJ
    Neonatology; 2022; 119(6):719-726. PubMed ID: 36126636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Minimally invasive surfactant therapy
    Elbaz Y; Portnov I; Lurie-Marcu B; Shinwell ES
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6802-6806. PubMed ID: 34024234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respiratory distress syndrome in preterm infants: possible impact of surfactant application techniques.
    Krajewski P; Pomianek T; Truszkowski K; Wieckowska K; Gorska M; Wielgos M
    Ginekol Pol; 2022; 93(9):750-755. PubMed ID: 35106747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of less invasive surfactant administration on cerebral oxygenation in preterm infants.
    Hanke K; Rausch TK; Paul P; Hellwig I; Krämer C; Stichtenoth G; Herz A; Wieg C; König IR; Göpel W; Herting E; Härtel C
    Acta Paediatr; 2020 Feb; 109(2):291-299. PubMed ID: 31310677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial.
    Pan R; Chen GY; Wang J; Zhou ZX; Zhang PY; Chang LW; Rong ZH
    Curr Med Sci; 2021 Jun; 41(3):542-547. PubMed ID: 34129204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
    Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
    Vento G; Pastorino R; Boni L; Cota F; Carnielli V; Cools F; Dani C; Mosca F; Pillow J; Polglase G; Tagliabue P; van Kaam AH; Ventura ML; Tana M; Tirone C; Aurilia C; Lio A; Ricci C; Gambacorta A; Consigli C; D'Onofrio D; Gizzi C; Massenzi L; Cardilli V; Casati A; Bottino R; Pontiggia F; Ciarmoli E; Martinelli S; Ilardi L; Colnaghi M; Matassa PG; Vendettuoli V; Villani P; Fusco F; Gazzolo D; Ricotti A; Ferrero F; Stasi I; Magaldi R; Maffei G; Presta G; Perniola R; Messina F; Montesano G; Poggi C; Giordano L; Roma E; Grassia C; Ausanio G; Sandri F; Mescoli G; Giura F; Garani G; Solinas A; Lucente M; Nigro G; Del Vecchio A; Petrillo F; Orfeo L; Grappone L; Quartulli L; Scorrano A; Messner H; Staffler A; Gargano G; Balestri E; Nobile S; Cacace C; Meli V; Dallaglio S; Pasqua B; Mattia L; Gitto E; Vitaliti M; Re MP; Vedovato S; Grison A; Berardi A; Torcetta F; Guidotti I; di Fabio S; Maranella E; Mondello I; Visentin S; Tormena F
    Trials; 2016 Aug; 17():414. PubMed ID: 27538798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks.
    Yang G; Hei M; Xue Z; Zhao Y; Zhang X; Wang C
    Medicine (Baltimore); 2020 Feb; 99(9):e19216. PubMed ID: 32118723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
    Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
    BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimal invasive surfactant therapy in preterm infants with respiratory distress syndrome: a single-center experience.
    Rallis D; Drogouti E; Karagianni P; Soubasi-Griva V; Tsakalidis C
    Minerva Pediatr (Torino); 2024 Feb; 76(1):72-78. PubMed ID: 33820400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction of less invasive surfactant administration (LISA), impact on diagnostic and therapeutic procedures in early life: a historical cohort study.
    Bugter IAL; Janssen LCE; Dieleman J; Kramer BW; Andriessen P; Niemarkt HJ
    BMC Pediatr; 2020 Sep; 20(1):421. PubMed ID: 32883280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome.
    Li XF; Cheng TT; Guan RL; Liang H; Lu WN; Zhang JH; Liu MY; Yu X; Liang J; Sun L; Zhang L
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):801-805. PubMed ID: 27924521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New modes of surfactant delivery.
    Chahin N; Rozycki HJ
    Paediatr Respir Rev; 2022 Sep; 43():38-43. PubMed ID: 34933823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.